Fig. 1.
Probability of developing myelodysplastic syndrome in 113 children with aplastic anemia treated with immunosuppressive therapy with or without granulocyte colony-stimulating factor.
Probability of developing myelodysplastic syndrome in 113 children with aplastic anemia treated with immunosuppressive therapy with or without granulocyte colony-stimulating factor.
